» Articles » PMID: 24246502

CMV-specific CD8+ T-cell Function is Not Impaired in Chronic Lymphocytic Leukemia

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2013 Nov 20
PMID 24246502
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

In chronic lymphocytic leukemia (CLL), CD8(+) T cells exhibit features of exhaustion and impaired functionality. Yet, reactivations of latent viruses such as cytomegalovirus (CMV) are uncommon in untreated CLL, suggesting that antiviral responses are uncompromised. We analyzed phenotypical and functional characteristics of CMV-specific CD8(+) T cells in CLL patients in comparison with age-matched healthy controls (HCs). Despite increased expression of the inhibitory receptors PD1, CD160, and CD244 on total CD8(+) T cells in CLL, expression levels of these markers were decreased on CMV-tetramer(+)CD8(+) T cells. Second, cytokine production upon stimulation with both phorbol 12-myristate 13-acetate/ionomycin and CMV-peptide-loaded antigen-presenting cells was intact in CMV-tetramer(+)CD8(+) T cells. Third, CMV-tetramer(+)CD8(+) T cells of CLL patients and HCs were equally effective in killing CMV-peptide-loaded target cells. Finally, quantitative imaging flow cytometry revealed that the proportion of CD8(+) T cells forming immunologic synapses with CMV-peptide-loaded B cells was intact. In conclusion, despite evidence for global T-cell dysfunction in CLL, we show here that CLL-derived CMV-specific CD8(+) T cells display lower expression of exhaustion markers and are functionally intact. These data indicate that the changes in the T-cell compartment in CLL may be more heterogeneous than presently assumed.

Citing Articles

Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy.

Britsch I, van Wijngaarden A, Helfrich W Cancers (Basel). 2023; 15(15).

PMID: 37568582 PMC: 10416821. DOI: 10.3390/cancers15153767.


Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors.

Cuburu N, Bialkowski L, Pontejo S, Sethi S, Bell A, Kim R Proc Natl Acad Sci U S A. 2022; 119(26):e2116738119.

PMID: 35749366 PMC: 9245622. DOI: 10.1073/pnas.2116738119.


Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells.

van Bruggen J, van der Windt G, Hoogendoorn M, Dubois J, Kater A, Peters F Blood Adv. 2022; 6(14):4185-4195.

PMID: 35580333 PMC: 9327552. DOI: 10.1182/bloodadvances.2022007034.


BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion.

Liu L, Cheng X, Yang H, Lian S, Jiang Y, Liang J Mol Cancer. 2022; 21(1):59.

PMID: 35193595 PMC: 8862474. DOI: 10.1186/s12943-022-01516-w.


Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling.

Wurzer H, Filali L, Hoffmann C, Krecke M, Biolato A, Mastio J Front Immunol. 2021; 12:619069.

PMID: 34108958 PMC: 8181408. DOI: 10.3389/fimmu.2021.619069.